Cargando…

Broad Antiviral Activity of Carbohydrate-Binding Agents against the Four Serotypes of Dengue Virus in Monocyte-Derived Dendritic Cells

BACKGROUND: Dendritic cells (DC), present in the skin, are the first target cells of dengue virus (DENV). Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) is present on DC and recognizes N-glycosylation sites on the E-glycoprotein of DENV. Thus, the DC-SIGN/E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alen, Marijke M. F., De Burghgraeve, Tine, Kaptein, Suzanne J. F., Balzarini, Jan, Neyts, Johan, Schols, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128091/ https://www.ncbi.nlm.nih.gov/pubmed/21738755 http://dx.doi.org/10.1371/journal.pone.0021658

Ejemplares similares

Dengue Virus Entry as Target for Antiviral Therapy
por: Alen, Marijke M. F., et al.
Publicado: (2012)

Human stem cell-derived hepatocyte-like cells support Zika virus replication and provide a relevant model to assess the efficacy of potential antivirals
por: Tricot, Tine, et al.
Publicado: (2018)

Synthetic strategy and antiviral evaluation of diamide containing heterocycles targeting dengue and yellow fever virus()
por: Saudi, Milind, et al.
Publicado: (2016)

A pan-serotype antiviral to prevent and treat dengue: A journey from discovery to clinical development driven by public-private partnerships
por: Goethals, Olivia, et al.
Publicado: (2023)

Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections(†)
por: De Clercq, Erik, et al.
Publicado: (2010)

The Viral Polymerase Inhibitor 7-Deaza-2’-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model
por: Zmurko, Joanna, et al.
Publicado: (2016)

Sulfated Escherichia coli K5 Polysaccharide Derivatives Inhibit Dengue Virus Infection of Human Microvascular Endothelial Cells by Interacting with the Viral Envelope Protein E Domain III
por: Vervaeke, Peter, et al.
Publicado: (2013)

Synthesis and evaluation of 3-alkynyl-5-aryl-7-aza-indoles as broad-spectrum antiviral agents
por: Martinez-Gualda, Belén, et al.
Publicado: (2022)

Lipophilic prodrugs of nucleoside triphosphates as biochemical probes and potential antivirals
por: Gollnest, Tristan, et al.
Publicado: (2015)

Synthesis and evaluation of imidazole-4,5- and pyrazine-2,3-dicarboxamides targeting dengue and yellow fever virus()
por: Saudi, Milind, et al.
Publicado: (2014)

γ‐Non‐Symmetrically Dimasked TriPPPro Prodrugs as Potential Antiviral Agents against HIV
por: Zhao, Chenglong, et al.
Publicado: (2020)

Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2
por: de la Guardia, Carolina, et al.
Publicado: (2018)

Sequential immunization induces strong and broad immunity against all four dengue virus serotypes
por: Hou, Jue, et al.
Publicado: (2020)

An Analogue of the Antibiotic Teicoplanin Prevents Flavivirus Entry In Vitro
por: De Burghgraeve, Tine, et al.
Publicado: (2012)

Antiviral activity of carbohydrate-binding agents against Nidovirales in cell culture
por: van der Meer, F.J.U.M., et al.
Publicado: (2007)

A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection
por: Abdelnabi, Rana, et al.
Publicado: (2022)

Application of the phosphoramidate ProTide approach to the antiviral drug ribavirin
por: Derudas, Marco, et al.
Publicado: (2010)

Glycosylation of dengue virus glycoproteins and their interactions with carbohydrate receptors: possible targets for antiviral therapy
por: Idris, Fakhriedzwan, et al.
Publicado: (2016)

In Vitro Antiviral Activity of α-Mangostin against Dengue Virus Serotype-2 (DENV-2)
por: Panda, Kingshuk, et al.
Publicado: (2021)

Higher Infection of Dengue Virus Serotype 2 in Human Monocytes of Patients with G6PD Deficiency
por: Chao, Yuan-Chang, et al.
Publicado: (2008)

Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro
por: Radoshitzky, Sheli R., et al.
Publicado: (2023)

Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies
por: Jasso-Miranda, Carolina, et al.
Publicado: (2019)

Synthesis and broad spectrum antiviral evaluation of bis(POM) prodrugs of novel acyclic nucleosides
por: Hamada, Manabu, et al.
Publicado: (2013)

Monocyte Recruitment to the Dermis and Differentiation to Dendritic Cells Increases the Targets for Dengue Virus Replication
por: Schmid, Michael A., et al.
Publicado: (2014)

Design, synthesis, antiviral and cytostatic activity of ω-(1H-1,2,3-triazol-1-yl)(polyhydroxy)alkylphosphonates as acyclic nucleotide analogues
por: Głowacka, Iwona E., et al.
Publicado: (2014)

Natural antiviral compound silvestrol modulates human monocyte‐derived macrophages and dendritic cells
por: Blum, Leonard, et al.
Publicado: (2020)

Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes
por: Sood, Ruchi, et al.
Publicado: (2015)

Identification of All Dengue Serotypes in Nepal
por: Malla, Sarala, et al.
Publicado: (2008)

Broad-Spectrum Antivirals and Antiviral Drug Combinations
por: Oksenych, Valentyn, et al.
Publicado: (2022)

Neutralization of Dengue Virus Serotypes by Sera from Dengue-Infected Individuals Is Preferentially Directed to Heterologous Serotypes and Not against the Autologous Serotype Present in Acute Infection
por: Auerswald, Heidi, et al.
Publicado: (2021)

Targeting the Viral Polymerase of Diarrhea-Causing Viruses as a Strategy to Develop a Single Broad-Spectrum Antiviral Therapy
por: Bassetto, Marcella, et al.
Publicado: (2019)

Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
por: Geraghty, Robert J., et al.
Publicado: (2021)

Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2
por: de la Guardia, Carolina, et al.
Publicado: (2017)

Potent antiviral activity of carbohydrate-specific algal and leguminous lectins from the Brazilian biodiversity
por: Gondim, Ana C. S., et al.
Publicado: (2019)

The α(1,2)‐mannosidase I inhibitor 1‐deoxymannojirimycin potentiates the antiviral activity of carbohydrate‐binding agents against wild‐type and mutant HIV‐1 strains containing glycan deletions in gp120
por: Balzarini, Jan
Publicado: (2007)

Antiviral effects of deoxynojirimycin (DNJ)-based iminosugars in dengue virus-infected primary dendritic cells
por: Perera, Nilanka, et al.
Publicado: (2022)

A Viral Polymerase Inhibitor Reduces Zika Virus Replication in the Reproductive Organs of Male Mice
por: Jacobs, Sofie, et al.
Publicado: (2019)

Broad-Spectrum Antiviral Therapeutics
por: Rider, Todd H., et al.
Publicado: (2011)

Broad-spectrum antiviral agents
por: Zhu, Jun-Da, et al.
Publicado: (2015)

Dengue Virus Serotype 3, Karachi, Pakistan
por: Jamil, Bushra, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_gnbp2412cq8dehqsn2nid54nfk